跳至主要内容
临床试验/NCT05790070
NCT05790070已完成不适用

The Potential Synergistic Effect of Combined Blood Flow Restriction Training and Betaine Supplementation on Skeletal Muscle Mechanotransduction-Associated Cell Signaling

Baylor University1 个研究点 分布在 1 个国家目标入组 20 人开始时间: 2021年2月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
20
试验地点
1
主要终点
insulin receptor substrate 1

研究概览

简要总结

The purpose of the study is to determine whether there is a synergistic effect via combining both low-load blood flow restriction (BFR) training and betaine supplementation loading (6g/day for 14 days) on skeletal muscle anabolic signaling pathways that is mediated by enhancements in intracellular water. These effects are proposed to be greater than either BFR training or betaine supplementation alone or compared to control conditions (high-load non-occluded and/or placebo supplementation).

详细描述

The purpose of the investigation is to determine whether the combination of blood flow restriction (BFR) training and betaine supplementation can synergistically augment phosphorylated targets associated with mechanotransduction and/or muscle protein synthesis relative to either modality alone and compared against control conditions (standard "high-intensity" resistance training and placebo supplementation) in healthy young males. Secondly, the investigators aim to determine if any potential synergistic effects are mediated by enhanced intracellular fluid volumes, as determined by the changes in water content between hydrated and dehydrated muscle samples, as well as through changes in both muscle and serum betaine concentrations. Finally, the investigators aim to assess differences in the aforementioned interventions on specific gene targets, the betaine/γ-aminobutyric acid transporter, myosin heavy chain I, IIa, and IIx lactate dehydrogenase A. Therefore, the specific aims of this study are to determine in healthy, young males: 1) whether combined BFR training and betaine supplementation significantly augment mechanotransductive growth-associated post-translational protein modifications via extra-to-intracellular fluid flux, alongside 2) potentially altered gene expression that otherwise characterizes phenotypical/biochemical changes in skeletal muscle.

The specific aims of the study are to determine whether:

  1. The combination of BFR training and betaine supplementation demonstrates significantly greater phosphorylated FAK, ERK1/2, IRS1, and p70S6K, commensurate with greater wet-to-dry hydration changes, relative to any other combinations between BFR training, standard "high-load" training, betaine supplementation, and/or placebo ingestion.
  2. The combination of BFR training and betaine supplementation will result in increased MYH2 gene expression, alongside decreases in MYH7 and MYH1 expression. Furthermore, this combination will also result in the highest degree of HIF-1 and Ldha, as well as the lowest BGT-1 gene expression relative to baseline levels.
  3. The combination of BFR training and betaine supplementation will result in a higher load-volume accumulated relative to BFR-alone, and will not be statistically different than high-load-placebo training. Therein, the high-load-betaine group will have the greatest load-volume amidst any other combination of conditions.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Other
盲法
Single (Participant)

入排标准

年龄范围
18 Years 至 35 Years(Adult)
性别
Male
接受健康志愿者
是

入选标准

  • •Only participants considered low risk for cardiovascular disease with no contraindications to exercise as outlined by the ACSM
  • •Have not consumed any nutritional supplements (aside from a multi-vitamin) one month prior to investigation
  • •Blood pressure <140/90mmHg
  • •Resting heart rate <90bpm-

排除标准

  • •sedentary individual as defined by the ACSM guidelines.
  • •inadequate resistance training experience (<12 months, <3x/week)
  • •vegetarian, vegan, or have dietary restrictions or supplements that potentially affect betaine metabolism.
  • •allergy to topical anesthetics.
  • •known metabolic or cardiovascular disorder including heart disease, arrhythmias, diabetes, thyroid disease, or hypogonadism.
  • •genetic disorders/polymorphisms that would act as direct contraindications to betaine supplementation (i.e. methyltetrahydrofolate reductase, hyperhomocysteinemia, etc.)
  • •bleeding disorder, history of pulmonary disease, hypertension, hepatorenal disease, musculoskeletal disorders, neuromuscular/ neurological diseases, autoimmune disease, cancer, peptic ulcers, anemia, or chronic infection (e.g., HIV).
  • •resting systolic/diastolic blood pressure and heart rate of more than 140/90 mmHg and 90, respectively.
  • •taking any blood thinning (e.g., warfarin, Jantoven, etc.), heart, pulmonary, thyroid, anti-hyperlipidemic, hypoglycemic, anti-hypertensive, endocrinologic (e.g, thyroid, insulin, etc), emotional/psychotropic (e.g., Prednisone, Ritalin, Adderall), or neuromuscular/neurological medications.
  • •taking anabolic androgenic steroids within the past year.

研究组 & 干预措施

Placebo

Placebo Comparator

3g/ twice daily (separated by ~12 hours) cellulose placebo for 14 days

干预措施: Placebo (Other)

Betaine Supplementation

Experimental

3g/twice daily (separated by ~12 hours) betaine anhydrous for 14 days

干预措施: Betaine (Dietary Supplement)

结局指标

主要结局

insulin receptor substrate 1

时间窗: 3 hours following exercise cessation

signalling adapter protein

gene expression of HIF-1

时间窗: 3 hours following exercise cessation

genes related to skeletal muscle adaptation

serum and muscle betaine concentrations

时间窗: 3 hours following exercise cessation

measure related to the supplementation protocol

gene expression BGT-1

时间窗: 3 hours following exercise cessation

genes related to skeletal muscle adaptation

gene expression MHC

时间窗: 3 hours following exercise cessation

genes related to skeletal muscle adaptation

serum/muscle phosphorylated FAK

时间窗: 3 hours following exercise cessation

Focal adhesion kinase

次要结局

  • exercise condition total load-volume.(immediately post exercise session)
  • pre-to-post exercise set tissue hydration(both pre and immediately post exercise session)
  • capillary blood lactate concentrations(both pre and immediately post exercise session)
  • set-to-failure repetition number(immediately post exercise session)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验